Cohort (n=165)
No
Answers are grounded in this paper and cite their sources.
The extent of myocardial viability assessed by LGE appeared to identify patients with a differential survival benefit from CABG in this retrospective, small cohort study. These findings raise interesting hypotheses that need to be validated in larger prospective studies.
No takes yet. Share an insight, caveat, or question.
Yap et al. (2020) conducted a cohort in Ischemic heart failure with severe left ventricular dysfunction (n=165). Myocardial non-viability (per unit increase in non-viable segments on CMR LGE) vs. Viable myocardium was evaluated on All-cause mortality (HR 1.17, 95% CI 1.01-1.37, p=0.04).
Synapse has enriched 10 related papers. Consider them for comparative context: